Your session is about to expire
← Back to Search
CO2 Exposure for Cognitive Impairment
N/A
Waitlist Available
Led By Howard Kipen, MD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before and immediately after each exposure
Awards & highlights
Study Summary
This trial will help researchers understand how CO2 exposure can lead to cognitive impairments.
Who is the study for?
This trial is for individuals who have been vaccinated against COVID-19 and weigh at least 110 pounds. It's not suitable for those with colorblindness, diabetes on insulin therapy, pregnant women, hearing impairments, recent asthma attacks, anxiety disorders or panic attacks treated with medication, cognitive-affecting medications like beta-blockers and CNS depressants, or a history of cardiovascular disease.Check my eligibility
What is being tested?
The study aims to understand how breathing in different levels of carbon dioxide (CO2) affects thinking abilities. Participants will be exposed to two CO2 concentrations: one similar to normal air (600 ppm) and another much higher (2500 ppm).See study design
What are the potential side effects?
While the study does not involve drugs or invasive procedures, high levels of CO2 exposure may cause discomfort such as headaches or dizziness. Cognitive functions might also be temporarily affected during the exposure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately before and immediately after each exposure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately before and immediately after each exposure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in PMN (polymorphonuclear leukocyte) activation from pre-exposure to post-exposure
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: High CO2 Exposure first, then low CO2 exposure second.Experimental Treatment2 Interventions
At the first study visit the subject is exposed to 2500 ppm CO2 for 2.5 hours and at the second study visit the subject is exposed to 600 ppm CO2 for 2.5 hours.
Group II: Low CO2 Exposure first, then high CO2 exposure second.Placebo Group2 Interventions
At the first study visit the subject is exposed to 600 ppm CO2 for 2.5 hours and at the second study visit the subject is exposed to 2500 ppm CO2 for 2.5 hours.
Find a Location
Who is running the clinical trial?
Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,208 Total Patients Enrolled
Howard Kipen, MDPrincipal InvestigatorProfessor
1 Previous Clinical Trials
24 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are pregnant.You have received a COVID-19 vaccine in the past.You have had an asthma attack within the past five years.You weigh at least 110 pounds.You cannot understand spoken instructions.You have been diagnosed with anxiety disorder or have a history of panic attacks and are currently taking medication for it.You are taking certain medications that may affect your ability to think clearly, such as beta-blockers or CNS depressants.You have a history of heart-related problems, including stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Low CO2 Exposure first, then high CO2 exposure second.
- Group 2: High CO2 Exposure first, then low CO2 exposure second.
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment criteria for this research trial inclusive of senior citizens?
"This trial requires candidates to be between 18 and 30 years old."
Answered by AI
Is this particular experiment accessible to participants at the moment?
"Affirmative. According to clinicaltrials.gov, the study that was initially posted on July 14th of 2022 is still recruiting patients. For this trial, only 12 people need to be enrolled from one site."
Answered by AI
What is the aggregate participation in this experiment?
"Affirmative. Clinicaltrials.gov provides evidence that this medical trial, posted on July 14th 2022 and last edited on the 19th of July, is actively seeking out 12 participants at a single site."
Answered by AI
Could I potentially qualify to participate in this experiment?
"This study requires 12 participants with cognitive decline aged 18-30. In addition, they must have been vaccinated against COVID-19 and weigh at least 110 lbs."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger